Gene Editing Evasion of COVID-19 vaccine-medicated mucosal immunity by SARS-CoV-2 Omicron Posted on May 10, 2022 by Editorial Staff Researchers depicted the evasion of the SARS-CoV-2 Omicron variant to mucosal immunity in SARS-CoV-2 vaccine recipients. Share on FacebookTweetFollow us Editorial Staff Simulating molecular dynamics of SARS-CoV-2 spike variants in the locked conformation Pharma showers John Thune with campaign cash